CAS NO: | 1256580-46-7 |
包装 | 价格(元) |
5mg | 询价 |
50mg | 询价 |
Cas No. | 1256580-46-7 |
别名 | 艾乐替尼; CH5424802; RO5424802; AF802 |
化学名 | 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile |
Canonical SMILES | CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6 |
分子式 | C30H34N4O2 |
分子量 | 482.62 |
溶解度 | ≥ 4.83mg/mL in DMSO with ultrasonic and warming |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | CH5424802 is a potent and selective ALK inhibitor. Anaplastic lymphoma kinase (ALK) is a tyrosine kinase that is constitutively activated in certain cancers. . In vitro: In cell free assays the IC50 of CH5424802 for enzyme activity of ALK was 1.9 nM; the dissociation constant (KD) value for ALK in an ATP-competitive manner was 2.4 nM. The inhibitory activity for two hot spot-activating mutations (F1174L and R1275Q) in neuroblastoma was comparable to that for wildtype ALK [1]. In vivo: In the NCI-H2228 model, oral administration of CH5424802 resulted in dose-dependent tumor growth inhibition (ED50 = 0.46 mg/kg) and tumor regression. Moreover, treatment of 20 mg/kg CH5424802 showed rapid tumor regression and tumor regrowth did not occur throughout the 4-week drug-free period [2]. Clinical trial: No clinical data are available currently. Reference: |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |